Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity.

PloS One
Adam S ColemanUtpal Pal

Abstract

Borrelia burgdorferi, the pathogen of Lyme disease, cycles in nature through Ixodes ticks and mammalian hosts. At least five Complement Regulator-Acquiring Surface Proteins (BbCRASPs) are produced by B. burgdorferi, which are thought to assist spirochetes in host immune evasion. Recent studies established that BbCRASP-2 is preferentially expressed in mammals, and elicits robust antibody response in infected hosts, including humans. We show that BbCRASP-2 is ubiquitously expressed in diverse murine tissues, but not in ticks, reinforcing a role of BbCRASP-2 in conferring B. burgdorferi defense against persistent host immune threats, such as complement. BbCRASP-2 immunization, however, fails to protect mice from B. burgdorferi infection and does not modify disease, as reflected by the development of arthritis. An infectious BbCRASP-2 mutant was generated, therefore, to examine the precise role of the gene product in spirochete infectivity. Similar to wild type B. burgdorferi, BbCRASP-2 mutants remain insensitive to complement-mediated killing in vitro, retain full murine infectivity and induce arthritis. Quantitative RT-PCR assessment indicates that survivability of BbCRASP-2-deficient B. burgdorferi is not due to altered expressi...Continue Reading

References

Jul 1, 1990·The Journal of Infectious Diseases·S W BartholdK D Moody
Feb 1, 1997·The Journal of Clinical Investigation·A M de Silva, E Fikrig
Jul 25, 2000·Emerging Infectious Diseases·R SmithS Palmer
Aug 3, 2000·The New England Journal of Medicine·R Medzhitov, C Janeway
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·J E Purser, S J Norris
Dec 13, 2000·The Journal of Biological Chemistry·J HellwageS Meri
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hanna JarvaSeppo Meri
Apr 16, 2002·Science·Ruslan Medzhitov, Charles A Janeway
Jul 18, 2002·The Journal of Experimental Medicine·Fang Ting LiangErol Fikrig
Aug 17, 2002·Infection and Immunity·T MeriP F Zipfel
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Antti AlitaloSeppo Meri
Jun 24, 2003·Infection and Immunity·Radha IyerIra Schwartz
Nov 26, 2003·Infection and Immunity·Sunlian FengStephen W Barthold
Jan 15, 2004·The Journal of Clinical Investigation·Utpal PalErol Fikrig
Feb 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Dorothee GrimmPatricia A Rosa
Feb 26, 2004·The Journal of Experimental Medicine·Xiaofeng F YangMichael V Norgard
Apr 16, 2004·The Journal of Clinical Investigation·Allen C SteereLisa Glickstein
May 19, 2004·International Journal of Medical Microbiology : IJMM·Peter KraiczyBrian Stevenson
Jul 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Devin D BolzJanis J Weis
Apr 1, 1993·Parasitology Today·E FikrigR A Flavell
Aug 5, 2005·Nature Medicine·Patricia Rosa
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chad S BrooksDarrin R Akins
Dec 22, 2005·Infection and Immunity·Chad S BrooksDarrin R Akins

❮ Previous
Next ❯

Citations

Feb 23, 2010·The Journal of Infectious Diseases·Manish KumarUtpal Pal
Nov 1, 2012·Inflammopharmacology·I R Kean, K L Irvine
Jul 21, 2011·Ticks and Tick-borne Diseases·N D van BurgelA P van Dam
Nov 6, 2009·Molecular Microbiology·Zhiming OuyangMichael V Norgard
Nov 26, 2015·Clinics in Laboratory Medicine·Mary Petzke, Ira Schwartz
Jul 30, 2014·Frontiers in Immunology·Theodoros Kelesidis
Oct 12, 2016·Frontiers in Immunology·Peter Kraiczy
Jan 23, 2019·Molecular Microbiology·Danielle M TuftsYi-Pin Lin
Sep 25, 2009·Clinical and Vaccine Immunology : CVI·Adam S Coleman, Utpal Pal
May 1, 2012·FEMS Immunology and Medical Microbiology·Melisha R KenedyDarrin R Akins
Apr 4, 2018·Proceedings of the National Academy of Sciences of the United States of America·Quentin BernardUtpal Pal
Feb 23, 2020·Frontiers in Cellular and Infection Microbiology·Yi-Pin LinPeter Kraiczy
Nov 16, 2018·Parasites & Vectors·Pavlina VechtovaLibor Grubhoffer
May 28, 2020·Trends in Parasitology·Yi-Pin LinPeter Kraiczy
Mar 16, 2021·Frontiers in Immunology·Sara R MooreViviana P Ferreira
Aug 15, 2013·MBio·Teresia HallströmPeter F Zipfel
Apr 17, 2019·Bioconjugate Chemistry·Jasmin FederizonJonathan F Lovell

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
lipidation
ELISA
electrophoresis

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.